Stemline Therapeutics Inc (NASDAQ:STML)
| 11.96 Data as of Jul 25 |  +0.10 / +0.84%Today’s Change | 10.68 Today|||52-Week Range 47.25 | -38.98% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2013 | Quarter 3 2013 | Quarter 4 2013 | Quarter 1 2014 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 71.0K | 71.0K | |
| Depreciation And Amortization | 0.00 | 38.3K | 38.3K | 38.3K | ||
| Operating Expenses | Gross Income | 0.00 | -38.3K | -- | -- | |
| General Expenses | 5.2M | 5.5M | 7.9M | 9.1M | ||
| Research And Development | 4.1M | 3.3M | 5.6M | 7.1M | ||
| Total Operating Expenses | 5.2M | 5.6M | 8.0M | 9.1M | ||
| Non-Operating Expenses | Operating Income | -5.2M | -5.6M | -7.9M | -9.0M | |
| Extraordinary Credit | 0.00 | 0.00 | 60.8K | 0.00 | ||
| Interest Expense On Debt | 297.9K | 0.00 | 11.8K | -- | ||
| Other Expenses | 0.00 | 0.00 | 189.2K | -7.9K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -5.5M | -5.6M | -7.7M | -9.0M | |
| Net Income | -5.5M | -5.6M | -7.7M | -9.0M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 9.8M | 12.5M | 12.8M | 12.9M | |
| Shares To Calculate EPS Diluted | 9.8M | 12.5M | 12.8M | 12.9M | ||
| Earnings Per Share | EPS | -$0.55 | -$0.45 | -$0.60 | -$0.70 | |
| EPS Diluted | -$0.55 | -$0.45 | -$0.60 | -$0.70 | ||
.
